Legislation to establish the biomedical innovation accelerator proposed by President Joe Biden must avoid duplicating NIH work by making it independent of the existing agency, top members of a House health panel agreed.
The health subcommittee on the House Energy and Commerce Committee held a hearing Thursday on a slate of 22 bills that the panel is largely eyeing to attach to must-pass FDA user fee legislation. Two of those bills would authorize the Advanced Research Projects Agency for Health, or ARPA-H. The White House wants the new agency to deliver medical breakthroughs in the same way that existing programs ...